Skip to content

Clinical trials

Glycogen Storage Disease Type II trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glycogen Storage Disease Type II Clear all

146 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20035
20043
20056
20078
20085
20093
20102
20116
20126
20138
20147
201510
20169
20176
20186
20195
20205
202110
20227
20237
20248
20254
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed69
Unknown status23
Recruiting20
Active, not recruiting12
Terminated8
Not yet recruiting5
Withdrawn4
Enrolling by invitation2
Approved for marketing2
Available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Genzyme, a Sanofi Company33
Duke University12
Amicus Therapeutics9
National Taiwan University Hospital9
University of Florida8
LMU Klinikum5
Sanofi4
O & O Alpan LLC3
Shionogi3
AskBio Inc2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glycogen Storage Disease Type II146
Glycogen Storage Disease11
Lysosomal Storage Diseases9
Gaucher Disease6
Myositis, Inclusion Body5
Neuromuscular Diseases5
Fabry Disease4
Glycogen Storage Disease Type V4
Muscular Atrophy, Spinal4
Muscular Diseases4

Trials

Showing 76 to 100 of 146. Each trial links to its page on Pharma Observatory.

46 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.